- Home
- AKRO vs HTGC Comparison
AKRO vs HTGC Comparison
Compare AKRO & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- HTGC
- Stock Information
- Founded
- AKRO 2017
- HTGC 2003
- Country
- AKRO United States
- HTGC United States
- Employees
- AKRO N/A
- HTGC N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- HTGC Investment Managers
- Sector
- AKRO Health Care
- HTGC Finance
- Exchange
- AKRO Nasdaq
- HTGC Nasdaq
- Market Cap
- AKRO 3.9B
- HTGC 3.2B
- IPO Year
- AKRO 2019
- HTGC 2005
- Fundamental
- Price
- AKRO $54.58
- HTGC $18.26
- Analyst Decision
- AKRO Strong Buy
- HTGC Buy
- Analyst Count
- AKRO 6
- HTGC 8
- Target Price
- AKRO $82.50
- HTGC $20.81
- AVG Volume (30 Days)
- AKRO 1.8M
- HTGC 897.9K
- Earning Date
- AKRO 08-08-2025
- HTGC 07-31-2025
- Dividend Yield
- AKRO N/A
- HTGC 10.30%
- EPS Growth
- AKRO N/A
- HTGC N/A
- EPS
- AKRO N/A
- HTGC 1.33
- Revenue
- AKRO N/A
- HTGC $491,549,000.00
- Revenue This Year
- AKRO N/A
- HTGC $5.22
- Revenue Next Year
- AKRO N/A
- HTGC $9.85
- P/E Ratio
- AKRO N/A
- HTGC $13.70
- Revenue Growth
- AKRO N/A
- HTGC 3.02
- 52 Week Low
- AKRO $21.02
- HTGC $15.65
- 52 Week High
- AKRO $58.40
- HTGC $22.04
- Technical
- Relative Strength Index (RSI)
- AKRO 68.00
- HTGC 57.09
- Support Level
- AKRO $53.05
- HTGC $17.88
- Resistance Level
- AKRO $56.49
- HTGC $18.10
- Average True Range (ATR)
- AKRO 2.44
- HTGC 0.24
- MACD
- AKRO -0.26
- HTGC 0.01
- Stochastic Oscillator
- AKRO 86.02
- HTGC 85.82
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.